AstraZeneca’s European stock rises as citizens snub their jab

AstraZeneca's European stock rises as citizens snub their jab

After battling with AstraZeneca over shipping delays and even questioning the effectiveness of its Covid-19 jab, EU countries are seeing the company’s gun stocks piling up – unused.

On Friday, France had administered 16% of the 1.1 million doses of the two-injection vaccine it had received since the first delivery in early February, according to the Ministry of Health. data. As of Thursday, Germany had administered just over a fifth of the 1.45 million doses, roughly the same proportion as Italy, which received more than a million doses. Spain used just under a third of a total of 808,000 doses on Friday.

The situation prompted several European leaders to denounce the …

Read Additional From Source

Copyright @ www.ft.com

News Highlights Finance

  • Headline: AstraZeneca’s European stock rises as citizens snub their jab
  • Check all news and articles from the Finance news updates.
Disclaimer: If you need to update/edit/remove this news or article then please contact our support team.
For Latest Updates Follow us on Google News
Bollyinside - US Local News & Breaking News Stories
Logo
Compare items
  • Total (0)
Compare
0